Business Wire - November 5, 2002
The $10,000 award recognizes individuals or institutions for accomplishments in the social, scientific, or medical arenas of human disease management. "SBRI is extremely honored by ITI's award," said Kenneth D. Stuart, Ph.D., president and director of SBRI. "SBRI's research seeks solutions to the diseases that ravage millions of lives each year. We seek to conduct great science in pursuit of a vision of healthy people, thriving communities and stable nations." Glenn Kawasaki, founder and president of ITI added, "Scientists at SBRI have established preeminence in the field of infectious disease research and education and empowerment in Third World countries, as well as outreach programs locally."
For more than 25 years, Seattle Biomedical Research Institute (SBRI) researchers have harnessed innovative science and the latest technologies to tackle some of the world's deadliest killers, including malaria, HIV/AIDS and tuberculosis. SBRI has established a world-wide reputation for its infectious disease research focused on disease treatment and vaccine development. More information about SBRI can be found at www.sbri.org.
International Therapeutics, Inc. (ITI) is a privately held Seattle biotechnology company dedicated to the discovery and development of novel anti-viral therapies. The present focus of the Company is to identify new, safe and effective ways to combat HIV, a virus infecting over 40 million people worldwide. For more information, visit www.internationaltherapeutics.com.
CONTACT: International Therapeutics, Inc.
Bret MacPherson, 206/329-3563
SOURCE: International Therapeutics, Inc.
021105
BW021101
Copyright © 2002 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .